Shawna provides senior leadership expertise to clients, advising on project planning and development, vendor selection, patient recruitment and retention strategies, and numerous other clinical activities. Additionally, she contributes to the development and harmonization of quality systems for pharmaceutical and biotechnology partners and led FDA mandated post-market surveillance study activities for a device client.
Previously, Shawna held two principle roles with MannKind Corporation, during which time she co-authored four trial abstracts/posters with diabetes focus. She spent six years as a Global Clinical Trial Leader for eleven diabetes trials, successfully launching their Phase II program in Russia and managing Phase I - III clinical trial activities, vendors and cross-functional teams in North America, Eastern and Western Europe and Latin America. Upon successful completion of the pivotal trials, Shawna transitioned out of her clinical trial lead role to became the Lead Medical Writer, responsible for the management and flow of 2000 safety narratives in support of the NDA filing.
Shawna holds a Bachelor of Science in Exercise Science from Castleton State College.